|
|
Vaccine Detail
|
11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha) |
| Vaccine Information |
- Manufacturer: ChinaVaccineSerum
- Type: Virus Like Particle
- Status: Clinical trial
- Host Species for Licensed Use: Human
- L1 HPV 52
gene engineering:
- Type: Recombinant protein preparation
- Detailed Gene Information: Click Here.
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
Baboon Response
- Vaccination Protocol: (Liu et al., 2015)According to the 0, 2, and 6 months immunization program, intramuscular injection of the upper arm deltoid muscle, 3 doses of the experiment vaccine
|
| References |
Liu et al., 2015: Liu C, Yao Y, Yang X, Bai H, Huang W, Xia Y, Ma Y. Production of Recombinant Human Papillomavirus Type 52 L1 Protein in Hansenula polymorpha Formed Virus-Like Particles. Journal of microbiology and biotechnology. 2015; 25(6); 936-940. [PubMed: 25639723].
|
|
